Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) CEO Jitendra Mohan sold 173,366 shares of Astera Labs stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $110.12, for a total value of $19,091,063.92. Following the completion of the transaction, the chief executive officer now owns 600,000 shares of the company’s stock, valued at $66,072,000. The trade was a 22.42 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Jitendra Mohan also recently made the following trade(s):
- On Thursday, November 21st, Jitendra Mohan sold 171,064 shares of Astera Labs stock. The stock was sold at an average price of $103.53, for a total value of $17,710,255.92.
- On Friday, October 11th, Jitendra Mohan sold 47,667 shares of Astera Labs stock. The stock was sold at an average price of $70.26, for a total value of $3,349,083.42.
Astera Labs Price Performance
NASDAQ:ALAB opened at $99.60 on Thursday. The stock’s 50 day simple moving average is $73.12 and its 200-day simple moving average is $60.57. Astera Labs, Inc. has a 12-month low of $36.22 and a 12-month high of $113.85.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of ALAB. Vanguard Group Inc. acquired a new position in Astera Labs during the first quarter worth $127,268,000. Price T Rowe Associates Inc. MD acquired a new position in Astera Labs during the first quarter worth $44,514,000. Janus Henderson Group PLC acquired a new position in Astera Labs during the first quarter worth $20,025,000. Rokos Capital Management LLP acquired a new position in Astera Labs during the first quarter worth $1,484,000. Finally, Linden Thomas Advisory Services LLC acquired a new position in Astera Labs during the second quarter worth $3,187,000.
Wall Street Analyst Weigh In
ALAB has been the subject of several recent analyst reports. Needham & Company LLC restated a “buy” rating and set a $65.00 target price on shares of Astera Labs in a research note on Wednesday, October 9th. JPMorgan Chase & Co. boosted their target price on Astera Labs from $70.00 to $110.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. Roth Mkm boosted their target price on Astera Labs from $80.00 to $105.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Citigroup initiated coverage on Astera Labs in a research note on Monday, November 18th. They set a “buy” rating and a $120.00 target price for the company. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on Astera Labs from $60.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Twelve investment analysts have rated the stock with a buy rating, According to MarketBeat.com, Astera Labs currently has a consensus rating of “Buy” and an average price target of $94.67.
Get Our Latest Stock Report on ALAB
Astera Labs Company Profile
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Further Reading
- Five stocks we like better than Astera Labs
- Want to Profit on the Downtrend? Downtrends, Explained.
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Consumer Discretionary Stocks Explained
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
- The 3 Best Blue-Chip Stocks to Buy Now
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.